https://www.selleckchem.com/pr....oducts/gsk2879552-2h
The TEMPI syndrome is a rare and acquired disorder characterized by five salient features (1) telangiectasias, (2) elevated erythropoietin and erythrocytosis, (3) monoclonal gammopathy, (4) perinephric fluid collections and (5) intrapulmonary shunting. Complete resolution of symptoms following treatment with plasma cell-directed therapy supports the hypothesis that that monoclonal antibody is causal and pathogenic. Understanding the basis of the TEMPI syndrome will depend on the identification of additional patients and a coordi
Like
Comment
Share
